Qyuns Therapeutics Unit Passes EU Qualified Person Audit; Shares Down 8%

MT Newswires Live

2025/10/13

Qyuns Therapeutics (HKG:2509) said its unit Jiangsu Cellularforce Biopharma has successfully passed the EU Qualified Person audit, confirming that its industrialization base meets European Union Good Manufacturing Practice standards, according to an Oct. 10 Hong Kong bourse filing.

Shares of the firm were down over 8% in Monday afternoon trade.

The audit, conducted over three days by a senior EU QP under EudraLex Volume 4 guidelines, recognized the unit's high-quality management system, advanced facilities, and technical capabilities.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2575642167"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575642167\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575642167?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-13 13:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575642167","market":"fut","top_or_hot":-1,"title":"Qyuns Therapeutics Unit Passes EU Qualified Person Audit; Shares Down 8%","media":"MT Newswires Live","content":"<html><body><p> Qyuns <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2509) said its unit Jiangsu Cellularforce Biopharma has successfully passed the EU Qualified Person audit, confirming that its industrialization base meets European Union Good Manufacturing Practice standards, according to an Oct. 10 Hong Kong bourse filing.</p><p>Shares of the firm were down over 8% in Monday afternoon trade.</p><p>The audit, conducted over three days by a senior EU QP under EudraLex Volume 4 guidelines, recognized the unit's high-quality management system, advanced facilities, and technical capabilities.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics Unit Passes EU Qualified Person Audit; Shares Down 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics Unit Passes EU Qualified Person Audit; Shares Down 8%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-10-13 13:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Qyuns <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2509) said its unit Jiangsu Cellularforce Biopharma has successfully passed the EU Qualified Person audit, confirming that its industrialization base meets European Union Good Manufacturing Practice standards, according to an Oct. 10 Hong Kong bourse filing.</p><p>Shares of the firm were down over 8% in Monday afternoon trade.</p><p>The audit, conducted over three days by a senior EU QP under EudraLex Volume 4 guidelines, recognized the unit's high-quality management system, advanced facilities, and technical capabilities.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2575642167","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575642167","pubTimestamp":1760333702,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Qyuns Therapeutics  said its unit Jiangsu Cellularforce Biopharma has successfully passed the EU Qualified Person audit, confirming that its industrialization base meets European Union Good Manufacturing Practice standards, according to an Oct. 10 Hong Kong bourse filing.Shares of the firm were down over 8% in Monday afternoon trade.The audit, conducted over three days by a senior EU QP under EudraLex Volume 4 guidelines, recognized the unit's high-quality management system, advanced facilities, and technical capabilities.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4539":"次新股","BK4156":"煤与消费用燃料","BK1161":"生物科技","02509":"荃信生物-B","BK4139":"生物科技","BK4007":"制药"},"translate_title":"Qyuns Therapeutics部门通过欧盟合格人员审核；股价下跌8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1,"LENZ":1.5},"content_text":"Qyuns Therapeutics (HKG:2509) said its unit Jiangsu Cellularforce Biopharma has successfully passed the EU Qualified Person audit, confirming that its industrialization base meets European Union Good Manufacturing Practice standards, according to an Oct. 10 Hong Kong bourse filing.Shares of the firm were down over 8% in Monday afternoon trade.The audit, conducted over three days by a senior EU QP under EudraLex Volume 4 guidelines, recognized the unit's high-quality management system, advanced facilities, and technical capabilities.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}